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a b s t r a c t
Trichomoniasis, caused by the protozoan Trichomonas vaginalis, is usually treated with metronidazole,
however resistance is on the rise. In this study, N-chlorotaurine (NCT), a new endogenous mild activeccepted 18 September 2010
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usceptible
-Chlorotaurine
chlorine compound for topical use, killed T. vaginalis in vitrowithin 15minof treatment at a concentration
of 55mM (1%), which is well tolerated by human tissue. The activity of NCT was further enhanced by
addition of ammonium chloride (NH4Cl). A combination of 5.5mM (0.1%) NCT plus 19mM (0.1%) NH4Cl
killed 100% of trichomonads within 5min.
© 2010 Elsevier B.V. and the International Society of Chemotherapy. Open access under CC BY-NC-ND license.xidant
n vitro
. Introduction
Trichomonas vaginalis is the causative agent of trichomoniasis,
he most common non-viral sexually transmitted disease world-
ide. Typical symptoms are vaginitis and cervicitis in women; in
en the infection can lead to chronic prostatitis syndrome [1].
etronidazole is the drug of choice for trichomoniasis, however
reatment during pregnancy is problematic [2] and resistance is
ncreasing [3,4].
In a previous study, we demonstrated the amoebicidal effect
f N-chlorotaurine (NCT) (Cl-HN-CH2-CH2-SO3Na), thereby estab-
ishing the activity of this compound against protozoa [5]. NCT,
he N-chloro derivative of the amino acid taurine produced by
ranulocytes and monocytes during the oxidative burst, is a long-
ived oxidant that can be synthesised chemically [6] and applied
opically for treatment of infections [7]. It has broad-spectrum
icrobicidal activity against bacteria, viruses, fungi and protozoa
5,7–9]. Phase I and II clinical studies have revealed high tolerabil-
ty and therapeutic effects of regular applications of 55mM (1%)
CT in the eye, sinuses, oral cavity, outer ear canal, skin ulcerations
nd urinary bladder [7,10].
The antimicrobial activity of NCT against bacteria [8], fungi
8,9] and free-living amoebae [5] can be enhanced markedly by
∗ Corresponding author. Tel.: +43 1 40490 79446; fax: +43 1 40490 79435.
E-mail address: julia.walochnik@meduniwien.ac.at (J. Walochnik).
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Open acceaddition of ammonium chloride (NH4Cl) owing to the formation
of monochloramine (NH2Cl) in equilibrium by transfer of the
active chlorine atom [6–9]. NH2Cl is more lipophilic than NCT and
penetrates microorganisms more rapidly. For special indications,
e.g. treatment of viral conjunctivitis, addition of NH4Cl to NCT
might be an advantage [7].
The aim of the current study was to investigate the activity of
NCT and its combination with NH4Cl against T. vaginalis in vitro.
2. Material and methods
A metronidazole-susceptible (ATCC 30001) and a
metronidazole-resistant (ATCC 50138) strain of T. vaginalis
were investigated for their susceptibilities to NCT. Both strains
were grown under microaerophilic conditions in trypticase–yeast
extract–maltose (TYM)medium [11] at 37 ◦C andwere subcultured
every 72h.
NCT was produced synthetically at Innsbruck Medical Uni-
versity (Innsbruck, Austria) and was used alone as well as in
combination with NH4Cl as previous studies had revealed a high
synergistic potential for this substance [6,8]. NCT (molecular
weight 181.57g/mol) [6] was used at ﬁnal concentrations of
between 5.5mM (0.1%) and 55mM (1%) dissolved in either TYM or
phosphate-buffered saline (PBS). Trichomonads were treated for
5, 15 and 60min at 37 ◦C. Short intervals were chosen because sta-
bility testing revealed that the oxidative capacity of 55mM NCT is
reduced by 15% after 1min, by 90% after 1h and by >95% after 2h in
ss under CC BY-NC-ND license.
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YM. NH4Cl was purchased from Sigma-Aldrich (Vienna, Austria)
nd was used in the molar ratio 1:3.4 and 1:29 (NCT:NH4Cl)
s in previous studies [5,8]. Control experiments revealed no
ntiparasitic effects of NH4Cl alone. Additional experiments with
.5mM (0.1%) NCT plus 19mM (0.1%) NH4Cl (1:3.4) in PBS instead
f TYM medium were performed to investigate the efﬁcacy in the
bsence of chlorine consumption caused by unspeciﬁc reactions
f NCT with the culture medium.
Viability of trichomonads was followed by phase contrast
icroscopy and trypan blue (0.4%) staining, and 50% and 90% effec-
ive concentrations (EC50 and EC90 values) were calculated using
on-linear regression models. Cytotoxicity of NCT against vaginal
pithelial cells (ATCC; CRL 2616) was investigated using the EZ4U
est (Biomedica GmbH, Vienna, Austria), which is a tetrazolium
eduction assay. All experiments were carried out in triplicate and
ere repeated in two independent set-ups. For each experiment,
control series without NCT and additives was included.
Single-factor analysis of variance (ANOVA) and Tukey’s HSD
est (SPSS 14.0; SPSS Inc., Chicago, IL) were used for statistical
nalyses. P-values of <0.05 were considered signiﬁcant.
. Results and discussion
NCT showed cytotoxic effects against both strains of T. vaginalis
ested. Treatmentwith 55mMNCT (1%), a concentrationwell toler-
ted by all human tissues tested so far [7], led to 100%killing of both
trains tested within 15min in TYM medium (Fig. 1). At lower con-
entrations in this medium, strain ATCC 30001 was more suscepti-
le than strain ATCC 50138. The EC50 of NCT was 9.0mM for strain
TCC 30001, whilst it was 28.7mM for strain ATCC 50138 after 1h
f treatment. EC90 values were 9.8mM and 36.7mM, respectively.
The activity of NCT was markedly enhanced by the addition of
H4Cl, explained by formation of the small and more lipophilic
onochloramine (NH2Cl), which penetrates pathogens better
han NCT and leads to faster oxidation of intracellular proteins
6–8]. In strain ATCC 30001, only one-third of the concentration
f NCT was needed to achieve 100% killing when NH4Cl was
dded, i.e. 17mM (0.3%) NCT plus 57mM (0.3%) NH4Cl (Fig. 1);
oreover, the killing time was reduced to 5min. This effect was
ven greater when experiments were carried out in PBS instead
f culture medium. In PBS, co-treatment with 5.5mM (0.1%) NCT
lus 19mM (0.1%) NH4Cl also resulted in complete killing of
richomonads within 5min (data not shown). Inactivation of NCT
nd the formed NH2Cl by reaction with constituents of the TYM
edium must be assumed to contribute signiﬁcantly to delayed
illing in thismedium, particularly at concentrations below10mM.
ig. 1. Treatment of Trichomonas vaginalis ATCC 30001 with N-chlorotaurine (NCT)
nd co-treatment with NH4Cl in trypticase–yeast extract–maltose (TYM) medium:
, 55mM (1%) NCT; , 10mM (0.18%) NCT; ©, 5.5mM (0.1%) NCT; , 17mM
0.3%) NCT+57mM (0.3%) NH4Cl; - - - -, control. Mean value of three indepen-
ent experiments; the standard deviation ranged between 0.14 and 0.21 log10 for
alues exceeding 4 log10 (not shown). P<0.01 versus control for all zero survival
alues.ntimicrobial Agents 37 (2011) 171–173
Such chlorine consumption in the presence of organic material, in
particular reducing thio compounds, is well known [6,7]. It may
also explain the relatively sharp threshold between highly active
and inactive concentrations of NCT (Fig. 1). In strain ATCC 50138,
higher concentrations of NH4Cl (molar ratio 1:29) were necessary
to achieve enhancement of activity in TYM medium.
The metronidazole-sensitive strain (ATCC 30001) was more
susceptible to NCT than the metronidazole-resistant strain
(ATCC 50138), and this difference was statistically signiﬁcant
(P<0.001). An approximately three- to four-fold concentration
of NCT required to kill 50% of the metronidazole-sensitive tri-
chomonads was required to achieve the same killing rate in the
metronidazole-resistant strain. Although the modes of action are
different, since both metronidazole and NCT produce oxidative
stress one could hypothesise that the more resistant strain has a
better anti-oxidative protection system. This may be the case, but
at the applied millimolar concentrations of NCT such mechanisms
would not be sufﬁcient. Since penetration of the pathogen rather
than oxidation of the surface is the decisive step for killing by NCT
[7], we assume that several factors, particularly differences in the
membrane composition, may play a major role as has already been
observed in other microorganisms [12].
In vivo studies have shown that 55mM NCT (1%) is well tol-
erated by human mucosal tissue [7]. The in vitro tolerability of
human cells in cell culture to NCT is known to be signiﬁcantly (ca.
50–100-fold) lower [13–15]. However, vaginal epithelial cells were
observed to be relatively resistant to NCT in the current study. The
EC50 of NCT for these cells in vitro was 5.5mM and the survival rate
was25%after treatmentwith55mMNCT for1h (Fig. 2). Tolerability
to NCT was altogether signiﬁcantly higher than to metronidazole,
the standard drug for treatment of trichomoniasis. Increased
tolerability of human cells to the agent in vivo compared with that
in vitro can be explained by the fact that within tissues the cells
are coherently organised in a structure affording better protection
to oxidative agents. This has already been proven with human skin
in vivo as well as human epidermis carcinoma cells in vitro [10].
The stability of the aqueous solution of NCT depends on
temperature. At 37 ◦C its oxidation capacity decreases to zero
within 3 weeks, whereas it remains at 75% after storage at room
temperature for 2 months [6]. At sites of inﬂammation, oxidation
capacity decreases more quickly owing to halogen-consuming
proteins. After 15min the oxidation capacity is reduced by 30–50%
and after 2h by up to 90% [8]. However, as trichomonads are killed
within 15min, and even faster with the addition of NH4Cl, these
decomposition rates are not likely to affect a possible therapeutic
approach against trichomoniasis. Moreover, since human exu-
dates demonstrated enhanced rather than decreased microbicidal
activity of 0.5–1% NCT after topical application [8,9], it may be
expected that NCT is also microbicidal against T. vaginalis in vivo
after topical application.
Fig. 2. Survival of vaginal epithelial cells treated for 1h with N-chlorotaurine (NCT)
(full diamond) or metronidazole (open square).
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In conclusion, we have shown that NCT has strong
richomonacidal effects that are further enhanced by the addition
f NH4Cl. Further investigations of its utility in T. vaginalis
nfections are required.
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